Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1339881
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1339881
DNA Repair Drugs Market with COVID-19 Impact Analysis, By Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 300 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
DNA repair drugs market size was valued at USD 6,005.2 Million in 2022, expanding at a CAGR of 12.8% from 2023 to 2030.
DNA repair drugs are defined as a class of pharmaceuticals that purpose to restore DNA functionality and integrity by helping to repair damaged DNA molecules. Moreover, these drugs are targeting particular DNA repair pathways and assist to restore DNA integrity as well as preventing the progression and development of several diseases, including cancer. The DNA repair drugs market is likely to witness significant growth due to increasing advancements and research activities in the field of molecular and genomics biology.
DNA Repair Drugs Market- Market Dynamics:
- Increasing cases of cancer and growing healthcare infrastructure to fuel the market demand.
- The increasing cases of cancer across the world have significantly raised the requirement for developing DNA damage response drugs for solving cancer unmet needs. These medications have hitherto unheard-of potential in providing a specific and effectively tolerated therapy method for boosting cancer survival rates. Moreover, DNA repair drugs are frequently associated with the idea of personalized medicine, where medical care is individualized based on a patient's genetic makeup as well as particular mutations. Thus, the drugs can be designed for selective genetic profiles; as a result, this trend helps to boost the potential market for these drugs. However, for market players, procuring regulatory approvals for DNA repair drugs could be a time-consuming and complex process that may restrain the market growth globally. Furthermore, the increasing healthcare expenditure and growing healthcare infrastructure in the emerging nation offer significant growth opportunities for DNA repair drug manufacturers. Additionally, these regions have an unmet need for effective treatments and a huge patient population creating a favorable market environment, which is projected to boost the DNA repair market growth.
DNA Repair Drugs Market- Key Insights:
- As per the analysis shared by our research analyst, the global DNA repair drugs market is estimated to grow annually at a CAGR of around 12.8% over the forecast period (2023-2030)
- The DNA repair drugs industry is projected to grow at a significant rate due to the rising incidence and prevalence of several cancers among the population increase the demand
- Based on drug type segmentation, PARP inhibitors was predicted to show maximum market share in the near future
- Based on application segmentation, cardiovascular diseases was the leading type in 2022
- On the basis of region, North America was the leading revenue generator during the forecast period
DNA Repair Drugs Market- Segmentation Analysis:
- The global DNA repair drugs market is segmented on the basis of drug type, application, distribution channel, and region.
- The market is divided into three categories based on drug type: alkylating agents, PARP inhibitors, topoisomerase inhibitors, and others. The PARP inhibitors segment is likely to possess the market share. The use of PARP inhibitors to target homologous recombination repair (HRR) pathways, tumors extensively in metastatic prostate cancer, and triple-negative breast cancer is expected to augment the market size over. Additionally, the utilization of PARP inhibitors including olaparib, niraparib, and rucaparib, in cancer patients with BRCA1/2 mutation and deficiency in HRR is projected to strengthen the segment value.
- The market is divided into four categories based on application: neurodegenerative diseases, oncological, cardiovascular diseases, and stroke. The cardiovascular diseases segment is expected to maintain its dominance over the forecast period. DNA repair drugs have the potential in treating numerous types of cardiovascular diseases like Parkinson's and Alzheimer's. Moreover, therapeutic options could be provided by DNA repair.
- The market is divided into two categories based on distribution channels: retail pharmacies, hospital pharmacies, and others. The hospital pharmacies segment is accounted to witness speedy growth. The segment growth is attributed due to the rising prevalence of cancer. Moreover, the specific nature of these drugs and their potential side effects, are likely to require monitoring, careful handling, and administration, as a result, such factors may propel the hospital pharmacies segment growth.
DNA Repair Drugs Market- Geographical Insights:
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
DNA Repair Drugs Market- Competitive Landscape:
The DNA repair drugs market is highly concentrated across the globe owing to the presence of key players. Additionally, various manufacturers hold a major share in their respective regions. Demand for technologically advanced products has increased in developed as well as emerging markets, due to the increase in the prevalence of cancer. Growth strategies adopted by market players are likely to drive the global market. In line with this, the strategies include mergers & acquisitions, innovative product launches, R&D activities, and partnerships. For instance, in March 2022, a Florida State University College of Medicine researcher made a discovery that alters our understanding of how the body's DNA repair process works and may lead to new chemotherapy treatments for cancer and other diseases.
Recent Developments:
Furthermore, in February 2023, Artios Pharma Limited (Artios) introduced the initiation of a randomized, Phase 2 expansion cohort in the ongoing Phase 1/2 trial evaluating its ataxia telangiectasia and Rad3-related ("ATR") Inhibitor, ART0380, for the treatment of platinum-resistant ovarian cancer in combination with gemcitabine.
Key features of the study:
- This proposed research study on DNA repair drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
- The report provides the client the latest up-to-date and trending insights about the DNA repair drugs market..
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for DNA repair drugs market.
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the DNA repair drugs market.
- Impact of COVID-19 on DNA repair drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on DNA repair drugs market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the DNA repair drugs market, we have also included competitive landscape and key innovator analysis for the DNA repair drugs market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the DNA repair drugs market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global DNA repair drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DNA REPAIR DRUGS MARKET KEY PLAYERS
- Johnson & Johnson
- Merck Kgaa
- GlaxoSmithKline plc
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Abbvie Inc.
- Pfizer Inc.
- Amgen Inc.
- Astrazeneca plc
- Bristol-Myers Squibb Co.
- Sanofi S.A.
- Bayer AG
- Eli Lilly
- Gilead Sciences Inc.
- Merck & Co. Inc.
- Novartis AG
GLOBAL DNA REPAIR DRUGS MARKET, BY DRUG TYPE
- Alkylating Agents
- PARP Inhibitors
- Topoisomerase Inhibitors
- Other
GLOBAL DNA REPAIR DRUGS MARKET, BY APPLICATION
- Neurodegenerative Diseases
- Oncological
- Cardiovascular Diseases
- Stroke
GLOBAL DNA REPAIR DRUGS MARKET, BY DISTRIBUTION CHANNEL
- Retail Pharmacies
- Hospital Pharmacies
- Others
GLOBAL DNA REPAIR DRUGS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1605
Table of Contents
1. DNA Repair Drugs Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. DNA Repair Drugs Market Snippet by Drug Type
- 2.1.2. DNA Repair Drugs Market Snippet by Application
- 2.1.3. DNA Repair Drugs Market Snippet by Distribution Channel
- 2.1.4. DNA Repair Drugs Market Snippet by Country
- 2.1.5. DNA Repair Drugs Market Snippet by Region
- 2.2. Competitive Insights
3. DNA Repair Drugs Key Market Trends
- 3.1. DNA Repair Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. DNA Repair Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. DNA Repair Drugs Market Opportunities
- 3.4. DNA Repair Drugs Market Future Trends
4. DNA Repair Drugs Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. DNA Repair Drugs Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. DNA Repair Drugs Market Landscape
- 6.1. DNA Repair Drugs Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. DNA Repair Drugs Market - By Drug Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Drug Type, 2022&2030 (%)
- 7.1.2. Alkylating Agents
- 7.1.3. PARP Inhibitors
- 7.1.4. Topoisomerase Inhibitors
- 7.1.5. Other
8. DNA Repair Drugs Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
- 8.1.2. Neurodegenerative Diseases
- 8.1.3. Oncological
- 8.1.4. Cardiovascular Diseases
- 8.1.5. Stroke
9. DNA Repair Drugs Market - By Distribution Channel
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
- 9.1.2. Retail Pharmacies
- 9.1.3. Hospital Pharmacies
- 9.1.4. Others
10. DNA Repair Drugs Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. DNA Repair Drugs Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. DNA Repair Drugs Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. DNA Repair Drugs Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. DNA Repair Drugs Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. DNA Repair Drugs Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- DNA Repair Drugs Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Johnson & Johnson
- 11.2.2. Merck Kgaa
- 11.2.3. GlaxoSmithKline plc
- 11.2.4. Abbott Laboratories
- 11.2.5. F. Hoffmann-La Roche Ltd.
- 11.2.6. Abbvie Inc.
- 11.2.7. Pfizer Inc.
- 11.2.8. Amgen Inc.
- 11.2.9. Astrazeneca plc
- 11.2.10. Bristol-Myers Squibb Co.
- 11.2.11. Sanofi S.A.
- 11.2.12. Bayer AG
- 11.2.13. Eli Lilly
- 11.2.14. Gilead Sciences Inc.
- 11.2.15. Merck & Co. Inc.
- 11.2.16. Novartis AG
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Product Code: ANV1605
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE DNA Repair Drugs Market: Drug Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Drug Type
- TABLE Global DNA Repair Drugs Market, by Drug Type2018-2030 (USD Million)
- TABLE DNA Repair Drugs Market: ApplicationSnapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global DNA Repair Drugs Market, by Application2018-2030 (USD Million)
- TABLE DNA Repair Drugs Market: Distribution Channel Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
- TABLE Global DNA Repair Drugs Market, by Distribution Channel 2018-2030 (USD Million)
- TABLE DNA Repair Drugs Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global DNA Repair Drugs Market, by Region 2018-2030 (USD Million)
- TABLE North America DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE North America DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
- TABLE North America DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
- TABLE North America DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
- TABLE Europe DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Europe DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
- TABLE EuropeDNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
- TABLE Europe DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
- TABLE Asia Pacific DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
- TABLE Asia Pacific DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
- TABLE Asia Pacific DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
- TABLE Latin America DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
- TABLE Latin America DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
- TABLE Latin America DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
- TABLE Middle East and Africa DNA Repair Drugs Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa DNA Repair Drugs Market, by Drug Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa DNA Repair Drugs Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa DNA Repair Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.